ALX ONCOLOGY HOLDINGS INC Operating Leases, Future Minimum Payments, Due in Two and Three Years
ALX ONCOLOGY HOLDINGS INC (ALXO) had Operating Leases, Future Minimum Payments, Due in Two and Three Years of $206.00 thousand as of 2020-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoAndThreeYears · last filed 2022-02-28
- 2020-12-31: Operating Leases, Future Minimum Payments, Due in Two and Three Years $206.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two and Three Years |
|---|---|
| 2020-12-31 | $206.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |